|
|
||||||||
Department of Bacteriology and Immunology, Washington University School of Medicine, St. Louis, Missouri
Abstract
Conclusions have been stated at the end of each of the foregoing parts, and are discussed further in the following papers. A summary will be found in paper III.
Footnotes
1 The author is indebted to Eli Lilly and Co. for making the publication of these papers possible.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |